141 related articles for article (PubMed ID: 1971432)
1. Clonidine, administered intracerebroventricularly in mice, produces an anti-analgesic effect which may be mediated spinally by dynorphin A (1-17).
Fujimoto JM; Arts KS
Neuropharmacology; 1990 Apr; 29(4):351-8. PubMed ID: 1971432
[TBL] [Abstract][Full Text] [Related]
2. Dynorphin A(1-17) mediates midazolam antagonism of morphine antinociception in mice.
Rady JJ; Fujimoto JM
Pharmacol Biochem Behav; 1993 Oct; 46(2):331-9. PubMed ID: 7903457
[TBL] [Abstract][Full Text] [Related]
3. Intracerebroventricular physostigmine-induced analgesia: enhancement by naloxone, beta-funaltrexamine and nor-binaltorphimine and antagonism by dynorphin A (1-17).
Fujimoto JM; Rady JJ
J Pharmacol Exp Ther; 1989 Dec; 251(3):1045-52. PubMed ID: 2574738
[TBL] [Abstract][Full Text] [Related]
4. Spinal dynorphin A (1-17): possible mediator of antianalgesic action.
Fujimoto JM; Arts KS; Rady JJ; Tseng LF
Neuropharmacology; 1990 Jul; 29(7):609-17. PubMed ID: 1974711
[TBL] [Abstract][Full Text] [Related]
5. Spinal kappa receptor-mediated analgesia of E-2078, a systemically active dynorphin analog, in mice.
Nakazawa T; Furuya Y; Kaneko T; Yamatsu K
J Pharmacol Exp Ther; 1991 Jan; 256(1):76-81. PubMed ID: 1671100
[TBL] [Abstract][Full Text] [Related]
6. Supraspinal flumazenil inhibits the antianalgesic action of spinal dynorphin A (1-17).
Rady JJ; Holmes BB; Fujimoto JM
Pharmacol Biochem Behav; 1998 May; 60(1):245-54. PubMed ID: 9610949
[TBL] [Abstract][Full Text] [Related]
7. Naloxone and norbinaltorphimine administered intracerebroventricularly antagonize spinal morphine-induced antinociception in mice through the antianalgesic action of spinal dynorphin A (1-17).
Holmes BB; Fujimoto JM
J Pharmacol Exp Ther; 1992 Apr; 261(1):146-53. PubMed ID: 1348537
[TBL] [Abstract][Full Text] [Related]
8. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the antianalgesic action of dynorphin A in mice by cholera toxin.
Arts KS; Fujimoto JM; Crain SM
Pharmacol Biochem Behav; 1993 Nov; 46(3):623-9. PubMed ID: 7904072
[TBL] [Abstract][Full Text] [Related]
10. Involvement of spinal kappa opioid receptors in the antagonistic effect of dynorphins on morphine antinociception.
Song ZH; Takemori AE
Life Sci; 1991; 48(15):1447-53. PubMed ID: 1672725
[TBL] [Abstract][Full Text] [Related]
11. Opioid antagonists: indirect antagonism of morphine analgesia by spinal dynorphin A.
Aksu F; Holmes BB; Fujimoto JM
Pharmacol Biochem Behav; 1993 Jun; 45(2):409-18. PubMed ID: 8101007
[TBL] [Abstract][Full Text] [Related]
12. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1993 Sep; 266(3):1430-8. PubMed ID: 8103794
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal administration of thiorphan, bestatin, desipramine and fluoxetine differentially potentiate the antinociceptive effects induced by beta-endorphin and morphine, administered intracerebroventricularly.
Suh HH; Tseng LL
Neuropharmacology; 1990 Mar; 29(3):207-14. PubMed ID: 2139187
[TBL] [Abstract][Full Text] [Related]
14. Involvement of dynorphin A and not substance P in the spinal antianalgesic action of capsaicin against morphine-induced antinociception in mice.
Arts KS; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 1992 May; 261(2):643-51. PubMed ID: 1374471
[TBL] [Abstract][Full Text] [Related]
15. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
[TBL] [Abstract][Full Text] [Related]
16. The antinociceptive activity of intrathecally administered amiloride and its interactions with morphine and clonidine in rats.
Ouyang H; Bai X; Huang W; Chen D; Dohi S; Zeng W
J Pain; 2012 Jan; 13(1):41-8. PubMed ID: 22154330
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting a spinal dynorphin A component enhances intrathecal morphine antinociception in mice.
Holmes BB; Fujimoto JM
Anesth Analg; 1993 Dec; 77(6):1166-73. PubMed ID: 7902680
[TBL] [Abstract][Full Text] [Related]
18. Antianalgesic action of dynorphin A mediated by spinal cholecystokinin.
Rady JJ; Holmes BB; Fujimoto JM
Proc Soc Exp Biol Med; 1999 Mar; 220(3):178-83. PubMed ID: 10193446
[TBL] [Abstract][Full Text] [Related]
19. Modulation of acute morphine tolerance by corticotropin-releasing factor and dynorphin A in the mouse spinal cord.
Song SH; Takemori AE
Life Sci; 1992; 51(2):107-11. PubMed ID: 1352026
[TBL] [Abstract][Full Text] [Related]
20. Pentobarbital administered intracerebroventricularly antagonizes morphine-induced antinociception in mice.
Wang FS; Fujimoto JM
J Pharmacol Exp Ther; 1993 Jun; 265(3):1361-8. PubMed ID: 8099619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
